Top News

AstraZeneca and Algen logos displayed on adjoining biotech buildings

INVESTMENT

17 Nov 2025

Can a New Pact Propel Gene Editing Into Its Next Era?

AstraZeneca and Algen team up on gene editing and AI to tackle immune diseases

Cell and gene therapy production equipment used in CRISPR drug development

REGULATORY

15 Jan 2026

FDA opens smoother lanes for CRISPR firms

Scientist using a pipette inside a laboratory biosafety cabinet

INNOVATION

9 Jan 2026

Why Gene Editing Suddenly Feels Inevitable

Latest News

REGULATORY
15 Jan 2026
FDA opens smoother lanes for CRISPR firms
PARTNERSHIPS
13 Jan 2026
CRISPR tries to crack the rare-disease problem
INNOVATION
9 Jan 2026
Why Gene Editing Suddenly Feels Inevitable
PARTNERSHIPS
16 Dec 2025
A 2021 Gene Editing Deal Still Shapes the Future of Cancer Care

CRISPR Breakthrough Brings Gene Editing Closer to Daily Care

Scientist using pipette for gene-editing research in laboratory

INNOVATION

12 Dec 2025

New trial results suggest gene editing could move from rare use to everyday medicine, pending regulators

Abstract CRISPR gene-editing illustration featuring DNA strands and illuminated edit points.

INNOVATION

5 Jun 2025

CRISPR Developers Eye Safer Path to the Clinic

Sector turns to next-generation delivery and risk controls as in vivo gene editing moves toward wider clinical use

Baby with feeding tube sticker supported by gloved clinicians in a medical setting.

PARTNERSHIPS

21 May 2025

Tiny Particles, Big Genetic Win!

CHOP, Penn, and Acuitas use lipid nanoparticles for rare genetic disorder, bypassing viral vectors for the first time in the US.

Branded Mammoth Biosciences packaging featuring mammoth logos arranged on a clean lab workspace.

INSIGHTS

15 May 2025

Can AI Supercharge the Battery Race?

Mammoth’s one-dose CRISPR delivery to muscle raises hopes for wider, safer genetic treatments.

4 5

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.